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Abstract
The study aimed to determine the effect of Erythropoietin on spermatogonia number, Sertoli cells and Leydig 
cells in white rat Wistar strain testis after ligation vas deferens release. Twenty-four Wistar strain eats were 
grouped into four group. The control group only performed an orchiectomy for testicular examination, ligation 
group vas deferens, group performed release ligation of vas deferens and group performed release ligation 
of vas deferens and given EPO injection with dose of 1000 iu/kg BW intraperitoneally for a week (three 
times per week). The observation of spermatogonium, Sertoli cells and Leydig cells by determined amount 
on 5 cross sections of seminiferous tubules used 400x light magnificent microscope with Hematoxylin Eosin 
staining. The result showed ligation of vas deferens had significant decreased spermatogonia number and 
Sertoli cells (p<0.05). There was no significant difference Leydig cells number after ligation of vas deferens 
(p>0.05). Meanwhile, release ligation of vas deferens had no significant different in spermatogonia, Sertoli 
cells and Leydig cells with ligation of vas deferens group. Besides, treatment ligation of vas deferens release 
and an EPO injection for a week also no significant different in number compared ligation release group of 
vas deferens.
Keywords: Vasectomy Reversal, Reactive Oxygen Species (ROS), Erythropoietin, Spermatogonium, Sertoli 
Cell, Leydig cell
Introduction
Vasectomy is most reliable form of male 
contraception and estimated 40 million to 60 million 
men worldwide had undergone vasectomy. Even though, 
vasectomy is very effective method but various problem 
can arise related to unclear patient information before 
action, surgical procedures, post-operative follow up and 
success rate1. Most common long term complications 
of vasectomy are scrotal pain with 1% reporting post-
operative pain and spontaneous recanalization of vas 
deferens which occurred between 0.03% and 1.2% after 
vasectomy procedure was performed.
There were 2% men who had vasectomy choose to 
have vasectomy reversal because their desire to have 
children. The vasectomy reversal request are increased 
Corresponding author:
Soetojo
E-mail: soetojo@fk.unair.ac.id
in men who undergo vasectomy at young age1,2. Most 
men had vasectomy reversal will faced reducing in 
their semen quality and require additional reproductive 
techniques to achieve conception. The success rate 
in vasectomy reversal patients is around 90%. Longer 
interval from patient undergoing vasectomy to reversal 
vasectomy, success rate for pregnancy is also getting 
lower3. 
There are many hypotheses mentioned that 
vasectomy will result in obstruction of vas deferens which 
increasing intratesticular pressure in testis and resulted 
decreasing in testicular blood pressure and increased 
oxidative stress in the testis4,5,6. Vasectomy will result in 
high hydrostatic pressure due to obstruction, excessive 
sperm accumulation and stimulate local inflammatory 
reaction process which is characterized by increment 
in leukocytes in sperm. The abnormalities of sperm in 
the seminiferous tubules which contribute to Reactive 
Oxygen Species (ROS) increment7.
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In contrast, vasectomy reversal will result in ROS 
increment which is greater than patients who do not 
have a vasectomy or those who have vasectomy8. When 
vasectomy reversal, long standing chronic inflammatory 
process activates even greater leukocyte activity in the 
vas deferens. Besides, pre existing immune mechanism 
which is formation of anti-sperm antibodies which 
stimulate another inflammatory reaction resulted in 
increment leukocyte activation. Reactive Oxygen 
Species (ROS) content in vasectomy reversal action is 
higher than for patients who have vasectomy resulting 
in disturbances in sperm motility and spermatogenesis8,9. 
There was decreased in Sertoli cells, spermatogonia 
and spermatids and increased in apoptosis in 
spermatogenesis process10. Lue et al. indicated that 
testicles weight and testosterone hormone had no 
significant changes but spermatogonia number and 
Sertoli cells decrease significant after 6th weeks and 
tubular atrophy occurred at 12th weeks11. 
Erythropoietin (EPO) is most important growth factor 
produced in kidney and works on Erythroid progenitor 
cells in bone marrow to prevent programmed cell death 
and response to hypoxic conditions12. In additions, 
Erythropoietin receptors in the body also found in the 
brain, liver, digestive system, lungs, testiscles and Leydig 
cells. EPO can affect steroidogenesis of mouse testicular 
Leydig cells by stimulating testosterone production and 
EPO intravenously can increase testosterone production 
in renal failure12.
Besides, Erythropoietin has function as anti-
apoptosis, anti-inflammatory and antioxidant by 
inhibiting ROS. The EPO given to mice testes had 
improved morphological testicular structure and 
repair germ cells by reducing apoptosis process and 
preventing inflammatory process so that ROS process 
could be inhibited12,13. EPO have benefits by increasing 
spermatogonia number, Sertoli cells and Leydig cells. 
Hence, EPO is expected to be alternative therapy for 
vasectomy reversal. .The study aimed to determine 
the effect of Erythropoietin on spermatogonia number, 
Sertoli cells and Leydig cells in white rat Wistar strain 
testis after ligation vas deferens release.
Methodology
The study was used experimental study with post 
test only control group design used male Wistar white 
rats (Rattus norvegicus). In additions, the treatment was 
in form of vasectomy ( ligation of vas deferens) which 
observed for seven weeks, release ligation and left for 
one week and EPO injection for one week (3 times per 
week). The effect on spermatogonia number, Sertoli 
cells and Leydig cells in the testes was observed after 
ligation of vas deferens.
In the study, a post-test only control group 
design study was used with assumption that variable 
measurement were only obtained after treatment and 
had criteria for random allocation. The sample used was 
Wistar strain of white rats (Rattus Norvegicus) which 
had criteria included aged between 10 weeks and 12 
weeks, body weight between 150 gram and 200 grams, 
healthy and not disabled. The white rats was obtained 
from breeding laboratory at Faculty of Veterinary 
Medicine, Airlangga University.
The samples were divided into four groups randomly 
with random numbers. Overall samples were 36 Wistar 
strain (Rattus norvegicus). The treatment consisted 3 
groups included one group treated with a vasectomy 
and observed for 7 weeks; one group with vasectomy 
and release ligation performed at 7th weeks and then 
observed for another one week and another group with 
vasectomy treatment and release ligation was carried out 
at 7th weeks and given EPO injection was give for one 
week (3 times per weeks).
The study was conducted at Reproductive 
Embryology section of Faculty of Veterinary Medicine, 
Airlangga University for experimental animal rearing 
places and Pathobiology section of Anatomical Pathology 
section of Faculty of Veterinary Medicine for anatomical 
pathology examination and immunohistochemistry of 
testicular tissue examined.
The independent variable was EPO administration 
in Wistar strain rats after release ligation of vas deferens. 
Meanwhile, dependent variables was spermatogonia 
number, Sertoli cells and Leydig cells and control 
variables included Wistar strain (Rattus norvegicus), rats 
age, weight, cage type, feed, temperature, air pressure, 
cage humidity, artificial reversal vasectomy by release 
ligation of vas deferens, vasectomy duration and EPO 
dose.
The normality and variance test were used as 
basis for determined hypothesis test to determine the 
differences in spermatogonia number, Sertoli cells and 
Leydig cells in the control group and treatment group. All 
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data process techniques were analyzed computerizable 
used SPSS software program. 
Result and Discussion
The data was analyzed used One Way ANOVA test. 
The result showed there were significant differences in 
Sertoli cells in each group with p<0.05. The analysis 
continued with Post Hoc test to determine differences 
in each group. There was significant difference in 
Sertoli cells number in the control group compared to 
group who received vasectomy (p<0.05), where Sertoli 
cells number in the control group was higher than in 
vasectomy group. In this study, the vasectomy had 
reduced Sertoli cells significantly. Besides, group with 
release ligation and group with release ligation and EPO 
found did not significantly affected Sertoli cells number 
(p>0.05). In additions, group with release ligation and 
group with release ligation and EPO found that there 
was no significant difference compared group with 
only vasectomy. The group with release ligation of vas 
deferens was observed had lower Sertoli cell than group 
with vasectomy which is released by ligation.
Table 1. Comparison of Post Hoc Tamhane analysis for Sertoli cells in ach group.
Group comparison Mean difference p value
Control vs vasectomy 10.43 0.00*
Control vs vasectomy+ release ligation 10.77 0.00*
Control vs vasectomy+ release ligation+ EPO 9.43 0.00*
Vasectomy vs vasectomy+ release ligation 0.33 1.00
Vasectomy vs vasectomy + release ligation +EPO -1.00 0.98
Vasectomy +release ligation vs vasectomy+ release ligation+EPO -1.33 0.98
Based on Post Hoc test, there was significant differences in spermatogonia cells number in the control group 
compared to group with vasectomy (p<0.05). In additions, spermatogonia cells number in control group is higher 
than group with vasectomy. This result showed vasectomy had reduced spermatogonia cells number. Meanwhile, 
release ligation did not affect spermatogonia cells number as well as release ligation and EPO given with p<0.05. 
The group with release ligation had low spermatogonia number than group with vasectomy while group with release 
ligation and EPO given had higher number of spermatogonia cells than group with vasectomy and release ligation.
Table 2. Comparison of Post Hoc Tamhane analysis on spermatogonia cells number in each group
Group comparison Mean difference p value
Control vs vasectomy 15.97 0.00*
Control vs vasectomy+ release ligation 16.80 0.09*
Control vs vasectomy+ release ligation+ EPO 9.90 0.08*
Vasectomy vs vasectomy+ release ligation 0.83 1.00
Vasectomy vs vasectomy + release ligation +EPO -6.06 0.42
Vasectomy +release ligation vs vasectomy+ release ligation+EPO -6.90 0.82
The visualization of microscopic description of cross section of seminiferous tubule in control group is 
shown in Figure 1.The visualization of microscopic view of cross section of seminiferous tubulegroup rats 
is shown in Figure 2. As for vasectomy group and release for one week , its visualization is shown in Figure 
3. Finally, for vasectomy group+ release of vas deferens+ one week IPO, its microscopic images is shown in 
Figure 4.
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Figure 1. Microscopic description of cross section of seminiferous tubule in control group. 
Description: Blue arrow sowed Leydig cell. Green arrows indicated spermatocyte cells. The orange 
arrow showed spermatogonia cells. Red arrow indicated Sertoli cells. Black arrows showed 
spermatid cells 
 
100x magnification 400x magnification 
 
 
Figure 2. Microscopic view of cross section of seminiferous tubule in 7 weeks vasectomy group rats. 
 
 
 
Figure 3. Microscopic view of cross section of seminiferous tubules in 7 weeks vasectomy group and 
release for one week 
 
 
 
Figure 4. Microscopic description of cross section of seminiferous tubules in 7 weeks vasectomy 
group+ release of vas deferens+ one week IPO 
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Discussion
A reversal vasectomy was an act of returning 
vasectomy by reconnected vas deferens either by 
vasovasostomy or vasoepididymostomy. The reversal 
vasectomy is usually performed in 2-6% men who 
had a vasectomy before. The success rates for reversal 
vasectomy were determined by several factors included 
duration between vasectomy and reversal vasectomy, 
operator skills and intra-operative and pre-operative 
factors1. The patency rate and success of pregnancy 
after reversal vasectomy was around 97% and 76%. 
Meanwhile, between 3 years and 8 years intervals the 
patency and success rates were around 88% and 53%.
Vasectomy was resulted in high hydrostatic pressure 
due to the obstruction, excessive sperm accumulation 
and stimulated local inflammatory reaction process 
which characterized by an increment in leukocytes in the 
sperm and abnormality of sperm in seminiferous tubules 
that played a role in increased Reactive Oxygen Species 
(ROS).
The inflammatory process had increased leukocytes 
and secrete pro-inflammatory cytokines such as TNF-α, 
IL-6, IL-8, NF-κB and TGF-β that increased ROS and 
iNOS(Inducible Nitric Oxygen) activity species14. In the 
testis, the cells expressed TNF-α receptors, IL-6 were 
sensitive to hypoxic conditions were spermatogonia. 
The leukocytes and IL-6 concentration in seminiferous 
tubules remained stable during release ligation of vas 
deferens treatment due chronic inflammatory process of 
vasectomy.
In this study, vasectomy significantly reduced 
spermatogonia and Sertoli compared to control group 
(p<0.05) because vasectomy in vas deferens tract was 
blocked so that obstruction occurred and there was an 
increase in intratesticular pressure in the testis. The 
inflammatory process had increased leukocytes and 
secrete proinflammatory cytokines such as TNF-α, IL-6 
which mediator had bind to TNF-α receptors (TNF-αR) 
and IL-6-R found in spermatogonia. 
Chronic inflammatory reactions due to vasectomy 
obstruction caused an increment in macrophages resulted 
in leucocyte infiltration into the plasma seminal15. 
The apoptosis activation process also increased ROS 
and NOS resulted in degeneration of the seminiferous 
tubules, the blood testicular barrier was damaged and 
spermatogonia number and Sertoli cells also decreased.
Meanwhile, there was no significant difference in 
Leydig cells after vasectomy with control group (p>0.05). 
Naik et al. had stated vasectomy did not affect significantly 
in the FSH hormones, LH and testosterone while Leydig 
cells plays a role in producing testosterone16,17. Leydig 
cells were interstitial compartment of testes along with 
macrophages and lymphocytes which were located in 
Leydig cells between seminiferous tubules. 
In this study, the reversal vasectomy was analogized 
to release of vasectomy ligation since vasectomy had 
performed also an artificial vasectomy by double ligation 
of vas deferens of mouse testes for 7 weeks with non-
absorbable threads and no any cutting either proximal 
to ligation of vas deferens or distal from ligation of vas 
deferens.
In group with vasectomy for 7 weeks and release 
ligation with left for one week, there was no statistically 
significant difference from spermatogonia number, 
Sertoli cells and Leydig cells with group with vasectomy 
for 7 weeks (p>0.05). The spermatogonia number, 
Sertoli cells and Leydig cells after release ligation of vas 
deferens had lower number than group with vasectomy. 
In reversal vasectomy, leukocytes and IL-6 in seminal 
plasma was remain stable due to chronic inflammatory 
vasectomy process and increased which affected ROS 
activities.
Furthermore, group with EPO injection after 
release ligation of vas deferens showed no significant 
difference in spermatogonia, Sertoli cells and Leydig 
cells compared to group with vasectomy. The number 
of spermatogonia cells, Sertoli cells and Leydig cells 
were observed increased on group with EPO injection 
after one week observation. EPO had function as an anti-
inflammatory, anti-apoptotic and antioxidant which also 
known that there were EPO receptors in the testes. 
Conclusion
In conclusions, Sertoli cells and spermatogonia 
number less than the control group. Meanwhile, Leydig 
cells number in vasectomy group was higher than control 
group. Sertoli cells, Leydig cells and spermatogonia 
in vasectomy and release ligation of vas deferens was 
higher compared group with vasectomy. Besides, Sertoli 
cells, Leydig cells and spermatogonia in vasectomy 
group and release ligation of vas deferens with EPO 
for one week also higher than group with vasectomy 
and release ligation of vas deferens. The administration 
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of EPO for one week did not affected spermatogonia, 
Sertoli cells and Leydig cells numbers in release ligation 
of vas deferens treatment.
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